玻璃体内注射布罗珠单抗治疗新生血管性年龄相关性黄斑变性后出现视网膜色素上皮撕裂并伴后葡萄膜炎 - Suppr

Retinal pigment epithelium rip with posterior uveitis after intravitreal brolucizumab in neovascular age-related macular degeneration.

作者信息

Dabir Supriya, Mohankumar Arthi, Rao Vaishnavi Prasad, Rajan Mohan

机构信息

Department of Retina and Vitreous, Rajan Eye Care Hospital Pvt Ltd., 5, Vidyodaya Second Street, T. Nagar, Chennai, Tamil Nadu, India.

出版信息

Indian J Ophthalmol. 2024 Feb 1;72(2):292-294. doi: 10.4103/IJO.IJO_712_23. Epub 2024 Jan 25.

DOI:10.4103/IJO.IJO_712_23

PMID:38273689

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10941935/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba66/10941935/1fd6d23b1475/IJO-72-292b-g001.jpg

相似文献

Retinal pigment epithelium rip with posterior uveitis after intravitreal brolucizumab in neovascular age-related macular degeneration.玻璃体内注射布罗珠单抗治疗新生血管性年龄相关性黄斑变性后出现视网膜色素上皮撕裂并伴后葡萄膜炎

Indian J Ophthalmol. 2024 Feb 1;72(2):292-294. doi: 10.4103/IJO.IJO_712_23. Epub 2024 Jan 25.

Real-Life Experience and Predictors of Visual Outcomes with Intravitreal Brolucizumab Switch for Treatment of Neovascular Age-Related Macular Degeneration.玻璃体内注射布罗利珠单抗转换治疗新生血管性年龄相关性黄斑变性的真实临床经验和预测结果。

Ophthalmologica. 2023;246(2):158-168. doi: 10.1159/000530544. Epub 2023 Apr 11.

Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment.Brolucizumab 治疗伴有色素上皮脱离的年龄相关性黄斑变性的难治性黄斑新生血管

Eur J Ophthalmol. 2024 Mar;34(2):487-496. doi: 10.1177/11206721231187663. Epub 2023 Jul 18.

Changes in the uninjected contralateral eye after intravitreal brolucizumab for exudative age-related macular degeneration.玻璃体内注射布罗利珠单抗治疗渗出性年龄相关性黄斑变性后对未注射侧眼的影响。

Eur J Ophthalmol. 2024 Jan;34(1):NP104-NP107. doi: 10.1177/11206721231187429. Epub 2023 Jul 9.

Retinal pigment epithelium apertures associated with subretinal fluid and acquired vitellifom lesions in non-neovascular age-related macular degeneration.视网膜色素上皮裂孔与非新生血管性年龄相关性黄斑变性中的视网膜下液及获得性卵黄样病变相关。

Can J Ophthalmol. 2022 Jun;57(3):e91-e94. doi: 10.1016/j.jcjo.2021.09.013. Epub 2021 Nov 3.

[Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration].[玻璃体内注射布罗芦izumab治疗新生血管性年龄相关性黄斑变性后双侧闭塞性血管炎]

Ophthalmologe. 2022 Jan;119(1):75-78. doi: 10.1007/s00347-021-01323-6. Epub 2021 Feb 11.

Full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration.在新生血管性年龄相关性黄斑变性患者玻璃体内注射布罗珠单抗后出现的全层黄斑裂孔。

Eur J Ophthalmol. 2025 Jan;35(1):NP16-NP19. doi: 10.1177/11206721241286708. Epub 2024 Sep 27.

Effect of Brolucizumab and Aflibercept on the Maximum Thickness of Pigment Epithelial Detachments and Sub-Retinal Pigment Epithelium Fluid in HAWK and HARRIER.布罗利珠单抗和阿柏西普对HAWK和HARRIER研究中色素上皮脱离及视网膜下色素上皮液最大厚度的影响。

Ophthalmol Retina. 2025 Jan;9(1):13-21. doi: 10.1016/j.oret.2024.07.012. Epub 2024 Jul 19.

[Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration].[布罗芦izumab治疗顽固性新生血管性年龄相关性黄斑变性的真实生活经验]

Ophthalmologe. 2022 Mar;119(3):258-264. doi: 10.1007/s00347-021-01474-6. Epub 2021 Aug 5.

Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration.布罗利珠单抗和法西单抗在新生血管性年龄相关性黄斑变性中的功能和形态学变化比较。

Graefes Arch Clin Exp Ophthalmol. 2024 Feb;262(2):589-599. doi: 10.1007/s00417-023-06241-8. Epub 2023 Sep 26.

本文引用的文献

Three cases of brolucizumab-associated retinal vasculitis treated with systemic and local steroid therapy.三例与布罗鲁单抗相关的视网膜血管炎经全身和局部类固醇治疗。

Jpn J Ophthalmol. 2021 Mar;65(2):199-207. doi: 10.1007/s10384-021-00818-8. Epub 2021 Feb 5.

Am J Ophthalmol Case Rep. 2020 Nov 10;20:100989. doi: 10.1016/j.ajoc.2020.100989. eCollection 2020 Dec.

Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations.多次玻璃体内注射布罗珠单抗后继发视网膜小动脉阻塞导致严重视力丧失。

Am J Ophthalmol Case Rep. 2020 Apr 2;18:100687. doi: 10.1016/j.ajoc.2020.100687. eCollection 2020 Jun.

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.HAWK 和 HARRIER：贝鲁珠单抗治疗新生血管性年龄相关性黄斑变性的 3 期、多中心、随机、双盲试验。

Ophthalmology. 2020 Jan;127(1):72-84. doi: 10.1016/j.ophtha.2019.04.017. Epub 2019 Apr 12.

Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration: A Randomized Controlled Study.单链抗体片段 VEGF 抑制剂 RTH258 治疗新生血管性年龄相关性黄斑变性：一项随机对照研究。

Ophthalmology. 2016 May;123(5):1080-9. doi: 10.1016/j.ophtha.2015.12.030. Epub 2016 Feb 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Retinal pigment epithelium rip with posterior uveitis after intravitreal brolucizumab in neovascular age-related macular degeneration.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

本文引用的文献